Used when the research compound is sold as a lyophilized vial
Description 5-Amino-1MQ 5 mg 5-Amino-1MQ is a small molecule investigated for its ability to inhibit nicotinamide N-methyltransferase (NNMT), an enzyme closely linked to cellular metabolism and energy regulation. Research suggests that blocking NNMT activity may influence NAD+ metabolism, fat cell function, and metabolic balance
Injections are advised to circumvent potential absorption challenges in the gastrointestinal tract, particularly for those with known issues like Crohn's disease or irritable bowel syndrome, providing a more immediate replenishment compared to oral supplements, which may not be fully absorbed
This process consumes cellular methyl donors and, critically, prevents nicotinamide from being recycled into NAD+
AOD-9604 may suit individuals who want to experiment with peptides, who find semaglutide's side effects intolerable, or who have a specific interest in its proposed cartilage-regenerative properties
Summary Summary Research into AOD-9604 suggests potential benefits for: Fat breakdown (lipolysis) Reduced fat storage (anti-lipogenesis) Weight regulation Improved lipid profile Cartilage protection However, AOD-9604 remains an experimental peptide , with human results still inconclusive